Armata Pharmaceuticals Inc
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California. Show More...
-
Website https://www.armatapharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.95 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2007-12 2008-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -6859.96 -7279.96 -140.0 -4479.97 -326.2 -278.6 -345.38 -30.52 -8.96 -2.55 -2.24 Dividends USD Payout Ratio % * Shares Mil 1.0 8.0 9.0 Book Value Per Share * USD 395.45 372.71 154.77 14.38 2.97 1.83 1.8 Free Cash Flow Per Share * USD -631.59 -326.15 -272.99 -206.44 -26.15 -9.38 -4.17 Return on Assets % -70.21 -116.33 -5.03 -222.85 65.57 -35.91 -97.71 -87.53 -105.19 -104.34 -77.51 Financial Leverage (Average) 1.75 1.71 8.33 2.47 1.87 1.44 1.4 1.74 1.32 Return on Equity % -149.28 -332.37 -8.58 -133.66 -216.39 -147.11 -149.46 -168.89 -108.31 Return on Invested Capital % -139.8 -335.28 -6.69 -133.66 -201.94 -147.11 -149.46 -129.5 -92.24 Interest Coverage -19.92 -25.55 Current Ratio 4.14 1.42 0.27 9.56 3.76 4.2 1.78 2.74 3.27 1.36 4.05 Quick Ratio 4.09 1.39 0.25 9.48 3.58 3.98 1.6 2.61 3.17 1.24 3.97 Debt/Equity 0.11 0.04